<?xml version="1.0" encoding="UTF-8"?>
<p id="p0195">Currently, for clinical treatment of influenza infection, there are only three classes of FDA (Food and Drug Administration)-approved antiviral drugs available, including M2 ion channel inhibitors (amantadine and rimantadine), neuraminidase inhibitors (oseltamivir, zanamivir, peramivir and laninamivir), and the most recently RNA polymerase inhibitors (balxavirmarboxil) [
 <xref rid="bib117" ref-type="bibr">117</xref>].
</p>
